LAURA BAKKE: Open Payments
NPI 1962978726 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 25 payments from 8 companies in 2025. Trend: 2023 $402 · 2024 $550 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $273 |
| Ardelyx, Inc. | 8 | $190 |
| Regeneron Healthcare Solutions, Inc. | 1 | $123 |
| GENZYME CORPORATION | 1 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Mirum Pharmaceuticals, Inc. | 1 | $20 |
| Celltrion USA Inc. | 1 | $16 |
Products named: RINVOQ, DUPIXENT, IBSRELA, ENTYVIO, CREON, XIFAXAN, Livmarli, VEGZELMA.
Industry payments across SD — which companies pay providers there.
